Latest news
PureIMS names Frank Lambert to advance commercialization of its Cyclops™ Dry Powder Inhaler (DPI)
Roden — February 10, 2023 — PureIMS, a clinical stage pharmaceutical company focused on developing and commercializing innovative inhaled therapies for systemic and respiratory diseases, has
Drug Delivery to the Lungs (DDL) poster on Epinephrine Cyclops™
Check out our scientific poster for DDL2022 on Epinephrine Cyclops™!
PureIMS present at DDL2022
PureIMS will be present at the Drug Delivery to the Lungs Conference 2022 in Edinburgh. Please visit our stand (246) and have a chat. We
PureIMS appoints Jaap Wieling, PhD, as new CEO
Roden — January 7, 2022 — PureIMS, a clinical stage pharmaceutical and medication systems company focused on developing and commercializing innovative inhaled therapies for systemic
Levodopa Cyclops™ in Dutch magazine ‘Tijdschrift voor Neurologie en Neurochirurgie (TNN)’
Inhaled levodopa for the rescue treatment of OFF episodes in Parkinson’s disease OFF episodes are an unmet medical need with a great impact on the
PureIMS participating in Biotech Showcase™ 2022
PureIMS aims to find a partner for its lead program Levodopa Cyclops™ Roden — December 22, 2021 — PureIMS today announced that it is participating
Categories
Categories
- Press release (10)
- Publication (2)
- Scientific publication (5)
- Status update (3)
- Vacancies (1)